Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00185913

Enrollment

Registered

2005-09-16

Start date

2000-09-30

Completion date

2008-05-31

Last updated

2010-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Brief summary

The purpose of the study is to identify a surrogate serum marker for tumor hypoxia in patients with lung cancers.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

- Newly diagnosed patients with lung cancer who are undergoing surgical resection of their tumors

Exclusion criteria

- Patients without non-small cell lung cancer

Countries

United States

Outcome results